• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

重症监护病房患者中耐碳青霉烯类肠道携带的危险因素及其对后续感染的影响:一项观察性研究。

Risk factor for intestinal carriage of carbapenem-resistant and the impact on subsequent infection among patients in an intensive care unit: an observational study.

作者信息

Qiao Fu, Huang Wenzhi, Gao Shan, Cai Lin, Zhu Shichao, Wei Li, Kang Yan, Tao Chuanmin, Zong Zhiyong

机构信息

Department of Infection Control, West China Hospital, Sichuan University, Chengdu, Sichuan, China.

Department of Infection Control, The First Affiliated Hospital, Zhengzhou University, Zhengzhou, Henan, China.

出版信息

BMJ Open. 2020 Sep 9;10(9):e035893. doi: 10.1136/bmjopen-2019-035893.

DOI:10.1136/bmjopen-2019-035893
PMID:32912943
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7482480/
Abstract

OBJECTIVES

To assess the incidence and the impact of carbapenem-resistant (CRAB) intestinal carriage on subsequent CRAB infection and to study risk factors of acquiring CRAB intestinal carriage among patients in intensive care unit (ICU).

DESIGN

Observational study including a case-control study and a retrospective cohort study.

SETTING

A 50-bed general ICU of a university hospital, China.

METHODS

From May 2017 to April 2018, an observational study was conducted in a 50-bed general ICU of a university hospital in China. Rectal swabs were collected from ICU patients on admission and thereafter weekly. A case-control study was performed to analyse risk factors of the acquisition of CRAB intestinal carriage in ICU using multiple logistic regression. A retrospective cohort study was performed to address whether intestinal CRAB carriage could lead to an increased likelihood of subsequent CRAB infection using subdistribution hazard model regarding death in the ICU as a competing risk event.

RESULTS

CRAB intestinal carriage was detected in 6.87% (66/961; 95% CI 5.27% to 8.47%) of patients on ICU admission, whereas 11.97% (115/961; 95% CI 9.91% to 14.02%) of patients acquired CRAB intestinal carriage during the ICU stay. Pancreatitis (OR 2.16, 95% CI 1.28 to 3.67), haematological disease (OR 2.26, 95% CI 1.42 to 3.58), gastric tube feeding (OR 3.35, 95% CI 2.03 to 5.51) and use of carbapenems (OR 1.84, 95% CI 1.11 to 3.07) were independent risk factors for acquiring CRAB intestinal carriage. The incidence of subsequent CRAB infection was 2.24-fold in patients with CRAB intestinal carriage compared with that in patients without (95% CI 1.48 to 3.39, p<0.001).

CONCLUSION

More patients acquired CRAB intestinal carriage during their ICU stay than had on admission. Severity of illness, acute pancreatitis, tube feeding and use of carbapenems were independent risk factors of acquisition of CRAB intestinal carriage. Patients with CRAB intestinal carriage are more likely to develop CRAB infection.

摘要

目的

评估耐碳青霉烯类鲍曼不动杆菌(CRAB)肠道定植的发生率及其对随后CRAB感染的影响,并研究重症监护病房(ICU)患者获得CRAB肠道定植的危险因素。

设计

包括病例对照研究和回顾性队列研究的观察性研究。

地点

中国一所大学医院的一间拥有50张床位的综合ICU。

方法

2017年5月至2018年4月,在中国一所大学医院的一间拥有50张床位的综合ICU进行了一项观察性研究。在ICU患者入院时及之后每周采集直肠拭子。采用多因素logistic回归进行病例对照研究,分析ICU中获得CRAB肠道定植的危险因素。采用亚分布风险模型,以ICU死亡作为竞争风险事件,进行回顾性队列研究,以探讨肠道CRAB定植是否会增加随后发生CRAB感染的可能性。

结果

6.87%(66/961;95%CI 5.27%至8.47%)的ICU入院患者检测到CRAB肠道定植,而11.97%(115/961;95%CI 9.91%至14.02%)的患者在ICU住院期间获得了CRAB肠道定植。胰腺炎(比值比2.16,95%CI 1.28至3.67)、血液系统疾病(比值比2.26,95%CI 1.42至3.58)、鼻饲(比值比3.35,95%CI 2.03至5.51)和碳青霉烯类药物的使用(比值比1.84,95%CI 1.11至3.07)是获得CRAB肠道定植的独立危险因素。与未发生CRAB肠道定植的患者相比,发生CRAB肠道定植的患者随后发生CRAB感染的发生率高2.24倍(95%CI 1.48至3.39,p<0.001)。

结论

在ICU住院期间获得CRAB肠道定植的患者比入院时更多。疾病严重程度、急性胰腺炎、鼻饲和碳青霉烯类药物的使用是获得CRAB肠道定植的独立危险因素。发生CRAB肠道定植的患者更有可能发生CRAB感染。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e17d/7482480/64df37f5d24c/bmjopen-2019-035893f02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e17d/7482480/5d7c3cebc241/bmjopen-2019-035893f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e17d/7482480/64df37f5d24c/bmjopen-2019-035893f02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e17d/7482480/5d7c3cebc241/bmjopen-2019-035893f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e17d/7482480/64df37f5d24c/bmjopen-2019-035893f02.jpg

相似文献

1
Risk factor for intestinal carriage of carbapenem-resistant and the impact on subsequent infection among patients in an intensive care unit: an observational study.重症监护病房患者中耐碳青霉烯类肠道携带的危险因素及其对后续感染的影响:一项观察性研究。
BMJ Open. 2020 Sep 9;10(9):e035893. doi: 10.1136/bmjopen-2019-035893.
2
Carbapenem-resistant versus carbapenem-susceptible Acinetobacter baumannii bacteremia in a Greek intensive care unit: risk factors, clinical features and outcomes.希腊重症监护病房耐碳青霉烯类 versus 碳青霉烯类敏感鲍曼不动杆菌菌血症:危险因素、临床特征和结局。
Infection. 2010 Jun;38(3):173-80. doi: 10.1007/s15010-010-0008-1. Epub 2010 Mar 12.
3
Adaptations of carbapenem resistant (CRAB) in the hospital environment causing sustained outbreak.耐碳青霉烯类肠杆菌科细菌(CRAB)在医院环境中的适应性导致持续暴发。
J Med Microbiol. 2021 Mar;70(3). doi: 10.1099/jmm.0.001345. Epub 2021 Mar 19.
4
Reduction in the acquisition rate of carbapenem-resistant Acinetobacter baumannii (CRAB) after room privatization in an intensive care unit.单间化病房后 ICU 获得碳青霉烯类耐药鲍曼不动杆菌(CRAB)的比例降低。
J Hosp Infect. 2022 Mar;121:14-21. doi: 10.1016/j.jhin.2021.12.012. Epub 2021 Dec 17.
5
Insights into the epidemiology, risk factors, and clinical outcomes of carbapenem-resistant infections in critically ill children.重症儿童耐碳青霉烯类感染的流行病学、危险因素和临床结局的研究进展。
Front Public Health. 2023 Nov 30;11:1282413. doi: 10.3389/fpubh.2023.1282413. eCollection 2023.
6
Rapid screening and early precautions for carbapenem-resistant carriers decreased nosocomial transmission in hospital settings: a quasi-experimental study.快速筛查和早期预防碳青霉烯类耐药菌携带者可降低医院环境中的医院感染传播:一项准实验研究。
Antimicrob Resist Infect Control. 2019 Jun 27;8:110. doi: 10.1186/s13756-019-0564-9. eCollection 2019.
7
[Risk factors and resistance patterns of invasive infection in Children].[儿童侵袭性感染的危险因素及耐药模式]
Zhonghua Er Ke Za Zhi. 2022 Aug 2;60(8):762-768. doi: 10.3760/cma.j.cn112140-20220502-00404.
8
Prospective multi-center evaluation on risk factors, clinical characteristics and outcomes due to carbapenem resistance in complex bacteraemia: experience from the Chinese Antimicrobial Resistance Surveillance of Nosocomial Infections (CARES) Network.复杂血流感染碳青霉烯耐药的危险因素、临床特征和结局的前瞻性多中心评估:来自中国医院感染抗菌药物耐药监测网(CARES)的经验。
J Med Microbiol. 2020 Jul;69(7):949-959. doi: 10.1099/jmm.0.001222.
9
Impact of antibiotic exposure on occurrence of nosocomial carbapenem-resistant Acinetobacter baumannii infection: a case control study.抗生素暴露对医院获得性耐碳青霉烯鲍曼不动杆菌感染发生的影响:病例对照研究。
J Infect Chemother. 2015 Feb;21(2):90-5. doi: 10.1016/j.jiac.2014.10.002. Epub 2014 Nov 25.
10
NDM-1- and OXA-23-producing Acinetobacter baumannii isolated from intensive care unit patients in Tunisia.从突尼斯重症监护病房患者中分离出携带 NDM-1 和 OXA-23 的鲍曼不动杆菌。
Int J Antimicrob Agents. 2018 Dec;52(6):910-915. doi: 10.1016/j.ijantimicag.2018.04.008. Epub 2018 Apr 14.

引用本文的文献

1
Amino acid competition shapes Acinetobacter baumannii gut carriage.氨基酸竞争影响鲍曼不动杆菌在肠道中的定植。
Cell Host Microbe. 2025 Aug 13;33(8):1396-1411.e9. doi: 10.1016/j.chom.2025.07.003. Epub 2025 Aug 4.
2
Assessment of the risk of aerosol transmission of CRKP during bronchoscopy in the intensive care unit.重症监护病房支气管镜检查期间耐碳青霉烯类肺炎克雷伯菌气溶胶传播风险评估
Antimicrob Resist Infect Control. 2025 Jul 6;14(1):81. doi: 10.1186/s13756-025-01603-9.
3
Identifying risk factors for carbapenem-resistant Acinetobacter baumannii carriage upon admission: a case-case control study.

本文引用的文献

1
Insight into : pathogenesis, global resistance, mechanisms of resistance, treatment options, and alternative modalities.深入了解:发病机制、全球耐药情况、耐药机制、治疗选择及替代方式。
Infect Drug Resist. 2018 Aug 21;11:1249-1260. doi: 10.2147/IDR.S166750. eCollection 2018.
2
Risk for subsequent infection and mortality after hospitalization among patients with multidrug-resistant gram-negative bacteria colonization or infection.耐多药革兰氏阴性菌定植或感染患者住院后的后续感染和死亡风险。
Antimicrob Resist Infect Control. 2018 Jul 31;7:93. doi: 10.1186/s13756-018-0388-z. eCollection 2018.
3
Risk Factors for Gastrointestinal Colonization and Acquisition of Carbapenem-Resistant Gram-Negative Bacteria among Patients in Intensive Care Units in Thailand.
入院时耐碳青霉烯鲍曼不动杆菌携带的危险因素识别:一项病例-病例对照研究
Antimicrob Resist Infect Control. 2024 Dec 20;13(1):153. doi: 10.1186/s13756-024-01500-7.
4
Amino acid competition shapes gut carriage.氨基酸竞争影响肠道定植。
bioRxiv. 2024 Oct 19:2024.10.19.619093. doi: 10.1101/2024.10.19.619093.
5
Risk factors for infection after carbapenem-resistant Acinetobacter baumannii colonization.碳青霉烯类耐药鲍曼不动杆菌定植后感染的危险因素。
Eur J Clin Microbiol Infect Dis. 2024 Nov;43(11):2191-2199. doi: 10.1007/s10096-024-04936-2. Epub 2024 Sep 16.
6
Rationale and evidence for the use of new beta-lactam/beta-lactamase inhibitor combinations and cefiderocol in critically ill patients.新型β-内酰胺/β-内酰胺酶抑制剂组合及头孢地尔在重症患者中应用的理论依据与证据
Ann Intensive Care. 2023 Jul 18;13(1):65. doi: 10.1186/s13613-023-01153-6.
7
Carbapenem-resistant : A challenge in the intensive care unit.耐碳青霉烯类:重症监护病房中的一项挑战。
Front Microbiol. 2022 Nov 10;13:1045206. doi: 10.3389/fmicb.2022.1045206. eCollection 2022.
8
A systematic literature review and expert consensus on risk factors associated to infection progression in adult patients with respiratory tract or rectal colonisation by carbapenem-resistant Gram-negative bacteria.一项关于呼吸道或直肠定植碳青霉烯类耐药革兰氏阴性菌的成年患者感染进展相关危险因素的系统文献回顾和专家共识。
Rev Esp Quimioter. 2022 Oct;35(5):455-467. doi: 10.37201/req/062.2022. Epub 2022 Jul 21.
9
Efficacy of Isolated from the Vagina of a Healthy Woman against Carbapenem-Resistant Infections In Vivo.健康女性阴道分离株对体内耐碳青霉烯类感染的疗效。
J Microbiol Biotechnol. 2021 Oct 28;31(10):1383-1392. doi: 10.4014/jmb.2103.03014.
10
[A systematic review and expert's analysis of risk factors of infections in adults due to carbapenem-resistant Pseudomonas aeruginosa or Acinetobacter baumannii in Spain].[西班牙耐碳青霉烯类铜绿假单胞菌或鲍曼不动杆菌所致成人感染危险因素的系统评价与专家分析]
Rev Esp Quimioter. 2021 Aug;34(4):298-307. doi: 10.37201/req/034.2021. Epub 2021 Apr 29.
泰国重症监护病房患者胃肠道定植和获得耐碳青霉烯类革兰氏阴性菌的危险因素。
Antimicrob Agents Chemother. 2018 Jul 27;62(8). doi: 10.1128/AAC.00341-18. Print 2018 Aug.
4
The Prevalence of Healthcare-Associated Infections in Mainland China: A Systematic Review and Meta-analysis.中国大陆的医源性感染患病率:系统评价和荟萃分析。
Infect Control Hosp Epidemiol. 2018 Jun;39(6):701-709. doi: 10.1017/ice.2018.60. Epub 2018 Apr 15.
5
Risk Factors and Outcomes Associated with Multidrug-Resistant Acinetobacter baumannii upon Intensive Care Unit Admission.入住重症监护病房时与多重耐药鲍曼不动杆菌相关的危险因素和结局。
Antimicrob Agents Chemother. 2017 Dec 21;62(1). doi: 10.1128/AAC.01631-17. Print 2018 Jan.
6
Carbapenem-resistant Enterobacteriaceae colonization (CRE) and subsequent risk of infection and 90-day mortality in critically ill patients, an observational study.碳青霉烯类耐药肠杆菌科细菌定植(CRE)与重症患者随后的感染风险及90天死亡率:一项观察性研究
PLoS One. 2017 Oct 12;12(10):e0186195. doi: 10.1371/journal.pone.0186195. eCollection 2017.
7
Active surveillance for carbapenem-resistant Acinetobacter baumannii in a medical intensive care unit: Can it predict and reduce subsequent infections and the use of colistin?在医疗重症监护病房对耐碳青霉烯鲍曼不动杆菌进行主动监测:它能否预测并减少后续感染及黏菌素的使用?
Am J Infect Control. 2017 Jun 1;45(6):667-672. doi: 10.1016/j.ajic.2017.01.016. Epub 2017 Feb 24.
8
Clinical and Pathophysiological Overview of Acinetobacter Infections: a Century of Challenges.不动杆菌感染的临床与病理生理学概述:一个世纪的挑战
Clin Microbiol Rev. 2017 Jan;30(1):409-447. doi: 10.1128/CMR.00058-16.
9
Evaluation of carriage and environmental contamination by carbapenem-resistant Acinetobacter baumannii.碳青霉烯类耐药鲍曼不动杆菌的携带和环境污染评估。
Clin Microbiol Infect. 2016 Nov;22(11):949.e5-949.e7. doi: 10.1016/j.cmi.2016.08.020. Epub 2016 Sep 3.
10
Point-prevalence survey of healthcare-associated infections in Beijing, China: a survey and analysis in 2014.中国北京医疗保健相关感染现患率调查:2014年的一项调查与分析
J Hosp Infect. 2016 Jul;93(3):271-9. doi: 10.1016/j.jhin.2016.03.019. Epub 2016 Apr 12.